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Inositol-phosphates, glucosamine and glucose-dphosphate blocked the effects of insulin on target protein phosphorylation in adipocytes, but the 
unsubstituted or sulphated erivatives of inositol or of glucose, or N-acetyl-glucosamine were without effect. The insulin stimulated tyrosine phos- 
phorylation of the insulin receptor was not affected. The sugar-phospates inositol-phosphate and glucosed-phosphate did not enter into the cells. 
They also blocked the insulin-like effects of a potential second messenger of insulin, a phosphooligosaccharide (POS), which has previously been 
shown to mimick the effects of insulin on protein phosphorylation in intact cells. 
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1. INTRODUCTION 
The molecular mechanisms whereby insulin controls 
metabolism of cells in target tissues have remained 
elusive and are partly understood only. Receptor 
autophosphorylation is known to be necessary for 
signal generation by insulin [1,2] and the function of 
target cellular proteins is acutely controlled by changes 
in their state of phosphorylation at serine or threonine 
residues in response to the hormone [3,4]. Recently, 
phospholipase C-catalyzed hydrolysis of a glycophos- 
pholipid (or a group of structurally similar glycophos- 
pholipids) has been suggested to take part in signalling 
by insulin [5-121. Thus insulin will generate diacylgly- 
cerol and a polar head-group, which is a phospho- 
oligosaccharide that seems to consist of inositol- 
monophosphate linked to non-acetylated glucosamine 
and several residues of galactose (5-8). When added to 
intact cells diacylglycerol increased glucose transport 
[ 10,131 while the phosphooligosaccharide (POS) closely 
mimicked the effects of insulin on target protein 
phosphorylation [9,14,15] as well as on activities of en- 
zymes in cells [12,16,17] and as isolated [5,18,19] 
Copenhagen. ‘ZSI-labelled protein G was a kind gift from Bo 
Akerstriim, University of Lund, and antibodies against phospho- 
tyrosine [20] were a kind gift from James Woodgett, Ludwig Cancer 
Institute, London. Isoproterenol, D-myo-inositol-hexakisphosphate, 
D-myo-inositol-l-monophosphate, myo-inositol-hexakissulphate, 
glucose-6-sulphate and D-glucosamine were from Sigma and D- 
glucose-6-phosphate from Boehringer. POS was purified from rat 
liver membranes as described [7,9]. 
2.2. Preparation and incubation of adipocytes 
Adipocytes were isolated by collagenase digestion of rat epididymal 
fat and incubated with [“PIphosphate as described [21]. “P-Labelled 
cells were than added to tubes containing the indicated final concen- 
trations of inositol-hexakisphosphate (or other sugar derivatives as in- 
dicated) and incubated for 5 min when insulin (or POS) was added 
and the incubations continued for a further 20 min. Reactions were 
terminated and processed for SDS-PAGE as detailed in [21]. SDS- 
PAGE was performed according to Laemmli [22] in 8% polyacryl- 
amide gels. Dried gels were autoradiographed against Hyperfilm /3- 
max (Amersham). The reported experiments have been performed at 
least twice with similar results. 
2.3. Determination of insulin receptor autophosphorylation 
2. EXPERIMENTAL PROCEDURES 
Isolated adipocytes at a concentration of 90 ~1 packed-cell volume 
per ml were prepared and incubated as described above, but without 
“P,. After SDS-PAGE (7% polyacrylamide) of total-cell protein 
from ca 1.5 X 10’ cells the gel was electrophoretically blotted against 
a nitrocellulose filter [23]. Immunoblotting analysis with antibodies 
against phospho-tyrosine [20] was performed exactly as described 
1201. The bound antibody was detected as in [20], but using iz51- 
labelled protein G [24] and autoradiography against Kodak X-Omat 
film with intensifying screen (DuPont). 
2.1. Materials 
Carrier-free ‘ZP,,D-myo-[2-3H]inositol-l-monophosphate, D- 
[U-i4C]glucose-6-phosphate, and [“HIsucrose were from Amersham. 
Insulin (porcine) and mono-[‘2*I]-(Tyr-A14)insulin was from Novo, 
2.4. Determination of ‘251-labelled insulin binding 
Correspondence address: P. Stralfors, Department of Physiological 
Chemistry, University of Lund, Box 94, S-22100 Lund, Sweden 
Mono [‘251]-(Tyr-A14)insulin, at 100 pM, binding to the adipocytes 
was determined as described [25]. Adipocytes were incubated as 
described above: after 5 min incubation in the presence of the dif- 
ferent sugar derivatives the labelled hormone was added for 20 min, 
non-specific binding was measured in the presence of an excess of 
unlabelled insulin. 
Published by Eisevier Science Publishers B. K (Biomedical Division) 
00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 169 
Volume 268, number 1 FEBS LETTERS July 1990 
3. RESULTS 
When added to intact adipocytes insulin induced an 
increased phosphorylation of phosphoproteins with ap- 
parent molecular masses 116 kDa and 40 kDa [9]. In the 
presence of ~yo-inositol-hexakisphosphate his effect 
of insulin was to a large extent blocked (Fig. 1A). 
Inositol-phosphate alone was seen also to slightly in- 
crease phosphorylation of the 65-kDa phosphoprotein, 
but this was not so for glucose derivatives that blocked 
the insulin effect (see below). As previously noted the 
effect of insulin on phosphorylation of the 40-kDa pro- 
tein was variable and not always apparent [9], Inositol- 
hexakisphosphate, similarly, blocked the ability of in- 
sulin to counteract the protein phosphorylations in- 
creased by CAMP elevation in response to isoproterenol 
(Fig. lB), so that in the presence of the inositol-phos- 
phate the effect of isoproterenol on protein phosphory- 
lation predominates over that of insulin. 
The insulin mimicker POS enhances the 
phosphorylation of the same 116-kDa and 40-kDa 
phosphoproteins as does insulin [9]. And, as was found 
for insulin, inositol-hexakisphosphate, and also 
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Fig. 1. Effect of inositol-hexakisphosphate on phosphorylation con- 
trol by insulin. Adipocytes were prepared and incubated as described 
in section 2. Shown are autoradiographs after SDS-PAGE of total 
cell-protein. (A) (Lane a) control with no additions; (b) 20 mM 
inositol-hexakisphosphate; (c) 150 pM insulin; (d) 150 pM insulin + 
20 mM inositol-hexakisphosphate. (B) (a) 100 nM isoproterenol; (b) 
100 nM isoproterenol + 150 pM insulin; (c) 100 nM isoproterenol + 
150 pM insulin + 20 mM inositol-hex~isphosphate; (d) control with 
no additions. The positions of the following marker proteins are in- 
dicated: myosin (205 kDa), &galactosidase (If6 kDa), glycogen 
phosphorylase (97 kDa), bovine serum albumin (67 kDa), and 
ovalbumin (43 kDa). Also indicated are IlbkDa, CkDa, 47-kDa 
and 40-kDa phosphoproteins. 
glucosed-phosphate (data not shown), blocked the in- 
creased phosphorylation of these phosphoproteins in 
response to POS (Fig. 2A). Inositol-phosphate seemed 
to block the effects of POS and insulin on protein 
phosphorylation through the same mechanism, because 
further addition of POS could overcome the inhibition 
of insulin due to inositol-phosphate (Fig. 2B). 
myo-Inositol-1-monophosphate (Fig. 3A), glucos- 
amine (Fig. 3B) or glucose-6-phosphate (data not 
shown), compounds that have structural similarities to 
POS, also blocked the effect of insulin on protein 
phosphorylation. Glucose, glucose-6-sulphate, N-ace- 
tyl-glu~osamine, at 80 mM, ~yu-inositol or myo- 
inositol-hexakissulphate, at20 mM, had no effect (data 
not shown). 
The insulin blocking effect of inositol-l-monophos- 
phate and glucose-6-phosphate appeared to be exerted 
at the outside of the cells because these radiolabelled 
compounds were not taken up by the cells during the 
course of incubation: 0.053 it 0.004% (mean + SD, 
n = 5) and 0.047 f O.O03(rlo of D-myo-[2-3H]inositol-l- 
monophosphate (Amersham) at 10 mM, or 0.055+ 
0.003% and 0.056 k 0.002% of D-[U-14C]glucose-6- 
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Fig. 2. Effect of inositol-hexakisphosphate on phosphorylation con- 
trol by POS. Adipocytes were prepared and incubated as described in 
section 2. Shown are autoradiographs after SDS-PAGE of total-cell 
protein. (A) (Lane a) control with no additions; (b) 1 nM insulin; (c) 
25 mM inositol-hexakisphosphate; (d) 15 PM POS + 25 mM inositol- 
hexakisphosphate; (e) 15 gM POS. (B) (a) control with no additions; 
(b) 200 pM insulin + 10 mM inosito~-hexakisphosphate; (c) 200 pM 
insulin + 10 mM inositol-h~akisphosphate + 25 $v% POS; (d) 200 
pM insulin. The positions of the marker proteins described in the 
legend to Fig. 1 are indicated. Also indicated are 116-kDa nd 40-kDa 
phosphoproteins. 
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phosphate (Amersham) at 50 mM was associated with 
the cells after < 0.5 and 25 min incubation, respective- 
ly, and centrifugation through dinonylphthalate [26]. 
This corresponded to the trapped medium around the 
cells as determined with [3H]sucrose [26]. 
These insulin-blockers did not obstruct the interac- 
tion between insulin and its receptor, since insulin 
stimulated tyrosine phosphorylation of a 95 kDa pro- 
tein, most likely the insulin receptor, was not inhibited 
by the insulin-blockers (Fig. 4). The insulin stimulated 
increase in tyrosine phosphorylation demonstrates that 
insulin can activate its receptor tyrosine protein kinase 
also in the presence of the insulin-blockers. Moreover, 
1251-labelled insulin binding to cells was not impaired by 
the insulin-blockers (data not shown). 
4. DISCUSSION 
Intracellular phosphorylation controlled by insulin 
was blocked without inhibiting insulin stimulation of its 
receptor tyrosine protein kinase activity, or insulin bin- 
ding to its receptor, the earliest events in insulin signall- 
ing. Hence, the blocking effect was likely exerted at a 
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Fig. 3. Effects of D-myo-inositol-I-monophosphate and D-glucos- 
amine on phosphorylation control by insulin. Adipocytes were 
prepared and incubated as described in section 2. Shown are 
autoradiographs after SDS-PAGE of total-cell protein. (A) (Lane a) 
control with no additions; (b) 20 mM inositol-1-monophosphate; (c) 
150 pM insulin; (d) 150 pM insulin + 20 mM inositol-l-monophos- 
phate. (B) (a) control with no additions; (b) 150 pM insulin; (c) 150 
pM insulin + 80 mM glucosamine; (d) 80 mM glucosamine. The posi- 
tions of the marker proteins described in the legend to Fig. 1 are in- 
dicated. Also incidated are 1 Hi-kDa and 40-kDa phosphoproteins. 
post-receptor step. The findings, furthermore, suggest 
that this post-receptor step is extracellular, because the 
intracellular phosphorylation control by insulin seemed 
to be blocked at the outside of the cell. Our data can not 
exclude that small amounts of the sugar phosphates 
entered the cells, but this is not likely to explain the 
observed inhibitions since: (i) inositol-phosphates are 
known not to enter cells, without prior permeabiliza- 
tion of the cells, in order to have effects on cellular 
metabolism; and (ii) glucose-6-phosphate is a natural 
constituent of the cytosol where its steady state concen- 
tration increases from 0.24 mM to 0.57 mM in response 
to insulin [27]. During preparation of this article it was 
reported that inositol phosphate and glucosamine 
blocked the effect of insulin also on lipogenesis [28]. 
POS exerts its insulin-like effects when added to in- 
tact cells [9]. It thus seems possible that a mechanism 
for cellular uptake of POS exists in adipocytes (cf [29]) 
and that this is inhibited by the, with POS structurally 
related, insulin-blockers. Phosphoinositol~yc~s that 
are structurally similar to POS anchor a number of pro- 
teins to the plasma membrane at the cell surface 
[30-343. Of these alkaline phosphatase [32], lipoprotein 
lipase 1341 and a proteoglycan ([31], L.A. Fransson, 
personal communication) has been shown to be released 
at the outside of cells in response to insulin stimulation. 
The proteoglycan, attached to the inositolglycan, was 
shown to be taken up by cells in a receptor mediated 
way and this uptake was blocked by inositol-phosphates 
and glucosed-phosphate [3 11. It is possible that similar 
mechanisms operate in the generation and action of 
POS in response to insulin. In support of such an idea 
the parent glycophospholipid of POS has been shown 
to be largely located to the outside of the plasma mem- 
brane [35,36] and substances imilar or identical to POS 
to be released in the incubation medium of insulin 
stimulated cells [12,32]. Furthermore, POS and insulin 
exhibited similar time-courses of protein phosphoryla- 
tion when added to intact cells [9]. 
a b c d e 
-97k 
Fig. 4. Effect of insulin-blockers on autophosphory~ation f the in- 
sulin receptor on tyrosine. Adipocytes were prepared and incubated 
as described in section 2. After SDS-PAGE the gel was electroblotted 
against a nitrocellulose filter for immunoblotting analysis with an- 
tibodies against phospho-tyrosine. ‘*‘I-Labelled protein G was used 
for detection of bound antibodies. Shown is an autoradiographic 
replica of the filter. (Lane a) control with no additions; (b) 9 nM in- 
sulin; 9 nM insulin + 20 mM inositol-hexakisphosphate; (d) 9 nM in- 
sulin + 80 mM glucose-&phosphate; (e) 9 nM insulin + 80 mM 
glucosamine. The P-subunit of the insulin receptor was identified by 
its apparent molecular mass and by its enhanced tyrosine 
phosphorylation in response to insulin. Indicated is the position of 
glycogen phospho~lase (97 kDa) run on the same gel. The region con- 
taming the P-subunit is shown. 
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